In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.
There is general agreement in the scientific community on the need to improve carcinogenicity testing and the assessment of human carcinogenic risk and to incorporate more information on mechanisms and modes of action into the risk assessment process. Advances in molecular biology have identified a...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
1998
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533274/ |